Zimmer Biomet has secured 510(k) clearance from the FDA for an advanced version of its ROSA Shoulder System.
The upgraded system includes improved robotically assisted glenoid reaming and humeral resection capabilities, and can support robotic total shoulder arthroplasty for anatomic and reverse techniques, according to a May 22 news release from Zimmer Biomet.
The ROSA system also utilizes ZBEdge, Zimmer’s orthopedic intelligence platform that helps surgeons plan, perform and monitor care.
“The foundation of this updated technology is grounded in real-world surgeon insights,” Brian Hatcher, global president of sports medicine, extremities, trauma, craniomaxillofacial and thoracic, said in the release. “We partnered closely with leading shoulder surgeons, listening to their experiences in the operating room to understand exactly what they need in the moments that matter: visibility, precision, efficiency and flexibility.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
